Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors

BACKGROUND: Reduced muscle mass has been associated with increased treatment complications in several tumor types. We evaluated the impact of skeletal muscle index (SMI) on prognosis and immune-related adverse events (IrAEs) in a cohort of recurrent/metastatic (R/M) head and neck squamous cell carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Arribas, Lorena, Plana, Maria, Taberna, Miren, Sospedra, Maria, Vilariño, Noelia, Oliva, Marc, Pallarés, Natalia, González Tampán, Ana Regina, Del Rio, Luis Miguel, Mesia, Ricard, Baracos, Vickie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267860/
https://www.ncbi.nlm.nih.gov/pubmed/34249760
http://dx.doi.org/10.3389/fonc.2021.699668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267860/
https://www.ncbi.nlm.nih.gov/pubmed/34249760
http://dx.doi.org/10.3389/fonc.2021.699668

Ejemplares similares